Literature DB >> 16563940

Approaches to patient education: emphasizing the long-term value of compliance and persistence.

Deborah T Gold1, Betsy McClung.   

Abstract

Approximately 50% of patients with chronic disease do not obtain optimal clinical benefit from treatment because of poor compliance with medication regimens. Lack of compliance is associated with poor clinical outcomes, increased hospitalizations, lower quality of life, and higher overall healthcare costs. Although poor compliance and persistence are common across many disease states, they may be particularly poor in treatment for asymptomatic chronic diseases such as osteoporosis. Patient education has been demonstrated to significantly improve compliance with medication across a broad range of conditions and disease severities. In a study in which patients received educational materials, referral for bone densitometry, and physician consultation, 67% were compliant with treatment after 6 months. Patient satisfaction with treatment has been linked to compliance with therapy; by improving patient care through fulfilling expectations for physician visits and providing frequent feedback, the healthcare provider can dramatically improve compliance. Self-management programs focusing on day-to-day management of chronic diseases have been shown to significantly improve heath behaviors and health status. Regardless of the strategy used, attention must be directed to identifying the patients least likely to persist with treatment and to providing the education and support these patients need to adhere to osteoporosis therapy.

Entities:  

Mesh:

Year:  2006        PMID: 16563940     DOI: 10.1016/j.amjmed.2005.12.021

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  48 in total

1.  Structural and reliability analysis of a patient satisfaction with cancer-related care measure: a multisite patient navigation research program study.

Authors:  Pascal Jean-Pierre; Kevin Fiscella; Karen M Freund; Jack Clark; Julie Darnell; Alan Holden; Douglas Post; Steven R Patierno; Paul C Winters
Journal:  Cancer       Date:  2010-10-04       Impact factor: 6.860

2.  Patient education strategies in dermatology: part 1: benefits and challenges.

Authors:  Matthew J Zirwas; Jessica L Holder
Journal:  J Clin Aesthet Dermatol       Date:  2009-12

3.  Patient education strategies in dermatology: part 2: methods.

Authors:  Matthew J Zirwas; Jessica L Holder
Journal:  J Clin Aesthet Dermatol       Date:  2009-12

4.  Osteoporosis knowledge among individuals with recent fragility fracture.

Authors:  L Giangregorio; L Thabane; A Cranney; A Adili; J deBeer; L Dolovich; J D Adachi; A Papaioannou
Journal:  Orthop Nurs       Date:  2010 Mar-Apr       Impact factor: 0.913

Review 5.  Racial/Ethnic and socioeconomic disparities in endocrine therapy adherence in breast cancer: a systematic review.

Authors:  Megan C Roberts; Stephanie B Wheeler; Katherine Reeder-Hayes
Journal:  Am J Public Health       Date:  2015-04-23       Impact factor: 9.308

6.  Osteoporosis knowledge and information needs in healthcare professionals caring for patients with fragility fractures.

Authors:  L Giangregorio; Pauline Fisher; A Papaioannou; J D Adachi
Journal:  Orthop Nurs       Date:  2007 Jan-Feb       Impact factor: 0.913

7.  Risk perception, worry and satisfaction related to genetic counseling for hereditary cancer.

Authors:  Cathrine Bjorvatn; Geir Egil Eide; Berit Rokne Hanestad; Nina Øyen; Odd E Havik; Anniken Carlsson; Gunilla Berglund
Journal:  J Genet Couns       Date:  2007-04       Impact factor: 2.537

8.  Drug attitude and adherence to anti-glaucoma medication.

Authors:  Samin Hong; Sung Yong Kang; Jong Uk Yoon; Uicheon Kang; Gong Je Seong; Chan Yun Kim
Journal:  Yonsei Med J       Date:  2010-02-12       Impact factor: 2.759

Review 9.  Osteoporosis therapies: evidence from health-care databases and observational population studies.

Authors:  Stuart L Silverman
Journal:  Calcif Tissue Int       Date:  2010-08-20       Impact factor: 4.333

10.  Impact of compliance and persistence with bisphosphonate therapy on health care costs and utilization.

Authors:  J A Sunyecz; L Mucha; O Baser; C E Barr; M M Amonkar
Journal:  Osteoporos Int       Date:  2008-03-20       Impact factor: 4.507

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.